Immunomodulatory and anti‐inflammatory potential of crocin in COVID‐19 treatment
The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the p...
Saved in:
Published in | Journal of Food Biochemistry Vol. 45; no. 5; pp. e13718 - n/a |
---|---|
Main Author | |
Format | Journal Article Web Resource |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.05.2021
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS‐CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF‐κB expression which leads to a wide range of immunomodulatory and anti‐inflammatory effects, and (d) crocin can reduce the viral‐induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS‐CoV2 infection.
Practical applications
Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS‐CoV2 infection because of its antioxidant and anti‐inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS‐Cov‐2 infection.
Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury
Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection
Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury |
---|---|
AbstractList | Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury
Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection
Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury The current COVID-19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS-CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF-κB expression which leads to a wide range of immunomodulatory and anti-inflammatory effects, and (d) crocin can reduce the viral-induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS-CoV2 infection. PRACTICAL APPLICATIONS: Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS-CoV2 infection because of its antioxidant and anti-inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS-CoV2-induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS-Cov-2 infection. The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel infection, finding effective drugs against this infection is crucial. We suggest the hypothesis that crocin, the main carotenoid of saffron, has the potential to limit the progression and severity of the SARS‐CoV2 infection for several reasons: (a) crocin possesses powerful antioxidant properties, (b) crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury, (c) crocin can upregulate PPARγ and downregulate NF‐κB expression which leads to a wide range of immunomodulatory and anti‐inflammatory effects, and (d) crocin can reduce the viral‐induced oxidative stress and downregulates ACE2 expression by activating Nrf2 pathway. We hope our hypothesis, corroborated by preclinical evidence, will inspire further targeted studies to test crocin as a beneficial drug against the SARS‐CoV2 infection. Practical applications Crocin is a natural antioxidant and the main active carotenoid components of saffron. We suggest the hypothesis that crocin has the potential to limit the progression and severity of the SARS‐CoV2 infection because of its antioxidant and anti‐inflammatory properties. Furthermore, this compound may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury. Therefore, we suggest further clinical studies on the effects of crocin against SARS‐Cov‐2 infection. Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and antioxidant properties has the potential to limit the progression and severity of the SARS‐CoV2 infection Crocin may prevent viral entry to host cells and reduce SARS‐CoV2‐induced lung injury |
Author | Ghasemnejad‐Berenji, Morteza |
AuthorAffiliation | 1 Department of Pharmacology and Toxicology School of Pharmacy Urmia University of Medical Sciences Urmia Iran |
AuthorAffiliation_xml | – name: 1 Department of Pharmacology and Toxicology School of Pharmacy Urmia University of Medical Sciences Urmia Iran |
Author_xml | – sequence: 1 givenname: Morteza orcidid: 0000-0001-5672-9202 surname: Ghasemnejad‐Berenji fullname: Ghasemnejad‐Berenji, Morteza email: morteza.ghasemnejad@yahoo.com organization: Urmia University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33817822$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9KxDAQxoMourt68QGk4E1YTZq0SS-C1n8rwl5Wr2GapNqlbda0VfbmI_iMPolZu4peDBMSJj--mck3RJu1rQ1C-wQfE79O5nmmjgnlRGygAeEsGrOIsE00wMTfhRBsBw2bZo4xDpOYbaMdSgXhIgwHaDapqq62ldVdCa11ywBq7XdbfLy9F3VeQlX1-YVtjU9DGdg8UM6qog58pNOHyYVnSRK0zkBbeWgXbeVQNmZvfY7Q_dXlLL0Z302vJ-nZ3VgxJsSYaW6yJNFUxxEzkIFSMahYRAyAJgISDoKTJA4T0FFMQ8KpwnHOQRssNDA6Qqe97qLLKqOVL-2glAtXVOCW0kIh_77UxZN8tC9ShBHGMfUCh2sBZ58707RybjtX-56lJwQXOPTYCB31lJ-6aZzJfyoQLFcOyJUD8ssBDx_87ukH_f5yD5AeeC1Ks_xHSt5enae96CdBt5Xo |
CitedBy_id | crossref_primary_10_1111_bcp_16124 crossref_primary_10_1055_a_2132_4984 crossref_primary_10_3389_fimmu_2023_1127358 crossref_primary_10_3390_ijerph192315823 crossref_primary_10_3390_ijms25063194 crossref_primary_10_1155_2021_7352938 crossref_primary_10_3390_antiox11081551 crossref_primary_10_1016_j_biopha_2022_113297 crossref_primary_10_1007_s00210_022_02262_y crossref_primary_10_1016_j_metop_2021_100111 crossref_primary_10_1186_s43014_023_00138_z crossref_primary_10_1515_jbcpp_2022_0028 crossref_primary_10_1016_j_mad_2022_111686 crossref_primary_10_1177_09603271231169911 crossref_primary_10_1007_s10876_023_02526_4 crossref_primary_10_1038_s41392_022_01249_8 crossref_primary_10_1016_j_jep_2021_114555 crossref_primary_10_1111_jfbc_14345 crossref_primary_10_1515_jbcpp_2021_0349 crossref_primary_10_3390_molecules27186005 crossref_primary_10_2139_ssrn_4110412 crossref_primary_10_1111_jfbc_14219 |
Cites_doi | 10.3390/molecules25092076 10.1016/j.fct.2020.111521 10.1016/j.mehy.2020.110102 10.1155/2017/1702967 10.1186/s12931-018-0766-3 10.1086/656044 10.3390/antiox9060518 10.1016/j.arcmed.2020.04.019 10.1016/j.lfs.2019.116794 10.1002/jcb.26335 10.1111/bph.15157 |
ContentType | Journal Article Web Resource |
Copyright | 2021 Wiley Periodicals LLC. 2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com |
Copyright_xml | – notice: 2021 Wiley Periodicals LLC. – notice: 2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com |
DBID | NPM AAYXX CITATION COVID 5PM |
DOI | 10.1111/jfbc.13718 |
DatabaseName | PubMed CrossRef Coronavirus Research Database PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Coronavirus Research Database |
DatabaseTitleList | PubMed Coronavirus Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: COVID name: Coronavirus Research Database url: https://proxy.k.utb.cz/login?url=https://search.proquest.com/coronavirus sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Economics Diet & Clinical Nutrition |
DocumentTitleAlternate | GHASEMNEJAD‐BERENJI |
EISSN | 1745-4514 |
EndPage | n/a |
ExternalDocumentID | 10_1111_jfbc_13718 33817822 JFBC13718 |
Genre | commentary Journal Article Commentary |
GroupedDBID | .3N .GA .Y3 05W 0R~ 10A 169 1OB 1OC 24P 29K 31~ 33P 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5HH 5LA 5VS 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 8VB 930 A03 A8Z AAESR AAEVG AAHBH AAHHS AAJEY AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACKIV ACPOU ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFGKR AFPWT AFZJQ AHEFC AIURR AIWBW AJBDE AJXKR AKVCP ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CAG COF CS3 D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DROCM DRSTM DU5 EBO EBS EBU EJD ESTFP F00 F01 F04 F5P FEDTE FZ0 G-S G.N G8K GODZA H.T H.X H13 HF~ HVGLF HZI HZ~ I-F J0M K1G K48 LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ O66 O9- OIG P2P P2W P2X P4D PALCI Q.N Q11 QB0 QWB R.K RHX RIWAO RJQFR ROL RX1 SAMSI SUPJJ TH9 UB1 UCJ W8V W99 WBFHL WBKPD WIH WIK WOHZO WQJ WRC WXSBR WYISQ XG1 ZL0 ZZTAW ~IA ~KM ~WT NPM AAYXX CITATION COVID 5PM |
ID | FETCH-LOGICAL-c4488-4d7eb99d3d654eabacc6ac6854aa398a97a8719629ad5632173c06f7ade08da43 |
IEDL.DBID | COVID |
ISSN | 0145-8884 |
IngestDate | Tue Sep 17 20:44:47 EDT 2024 Thu Oct 10 19:45:05 EDT 2024 Fri Aug 23 02:15:19 EDT 2024 Wed Oct 16 00:43:24 EDT 2024 Sat Aug 24 01:05:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | COVID-19 NF-κB SARS-CoV2 crocin Nrf2 PPARγ |
Language | English |
License | 2021 Wiley Periodicals LLC. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4488-4d7eb99d3d654eabacc6ac6854aa398a97a8719629ad5632173c06f7ade08da43 |
ORCID | 0000-0001-5672-9202 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8250063 |
PMID | 33817822 |
PQID | 2508780206 |
PQPubID | 4686273 |
PageCount | 3 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8250063 proquest_journals_2508780206 crossref_primary_10_1111_jfbc_13718 pubmed_primary_33817822 wiley_primary_10_1111_jfbc_13718_JFBC13718 |
PublicationCentury | 2000 |
PublicationDate | May 2021 |
PublicationDateYYYYMMDD | 2021-05-01 |
PublicationDate_xml | – month: 05 year: 2021 text: May 2021 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Hoboken |
PublicationTitle | Journal of Food Biochemistry |
PublicationTitleAlternate | J Food Biochem |
PublicationYear | 2021 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2018; 19 2020; 25 2019; 235 2020; 177 2017; 2017 2020; 51 2018; 119 2019; 22 2020; 143 2010; 202 2020; 9 e_1_2_4_10_1 e_1_2_4_11_1 e_1_2_4_12_1 e_1_2_4_3_1 e_1_2_4_2_1 e_1_2_4_5_1 Zeinali M. (e_1_2_4_13_1) 2019; 22 e_1_2_4_4_1 e_1_2_4_7_1 e_1_2_4_6_1 e_1_2_4_9_1 e_1_2_4_8_1 |
References_xml | – volume: 19 start-page: 58 issue: 1 year: 2018 article-title: Crocin attenuates cigarette smoke‐induced lung injury and cardiac dysfunction by anti‐oxidative effects: The role of Nrf2 antioxidant system in preventing oxidative stress publication-title: Respiratory Research – volume: 235 year: 2019 article-title: Crocin attenuates lung inflammation and pulmonary vascular dysfunction in a rat model of bleomycin‐induced pulmonary fibrosis publication-title: Life Sciences – volume: 2017 start-page: 1 year: 2017 end-page: 11 article-title: The hepatoprotective and MicroRNAs downregulatory effects of crocin following hepatic ischemia‐reperfusion injury in rats publication-title: Oxidative Medicine and Cellular Longevity – volume: 25 start-page: 2076 issue: 9 year: 2020 article-title: Pharmacological (or synthetic) and nutritional agonists of PPAR‐γ as candidates for cytokine storm modulation in COVID‐19 disease publication-title: Molecules – volume: 177 start-page: 4967 issue: 21 year: 2020 end-page: 4970 article-title: The potential of cannabidiol in the COVID‐19 pandemic publication-title: British Journal of Pharmacology – volume: 9 start-page: 518 issue: 6 year: 2020 article-title: Nrf2 activator PB125® as a potential therapeutic agent against COVID‐19 publication-title: Antioxidants – volume: 119 start-page: 1746 issue: 2 year: 2018 end-page: 1754 article-title: Crocin reduces ‐induced airway inflammation and NF‐κB signal activation publication-title: Journal of Cellular Biochemistry – volume: 22 start-page: 334 issue: 4 year: 2019 article-title: Immunoregulatory and anti‐inflammatory properties of (Saffron) and its main active constituents: A review publication-title: Iranian Journal of Basic Medical Sciences – volume: 51 start-page: 384 issue: 5 year: 2020 end-page: 387 article-title: Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS‐CoV) infection publication-title: Archives of Medical Research – volume: 143 start-page: 111521 year: 2020 article-title: Crocin: A fighter against inflammation and pain publication-title: Food and Chemical Toxicology – volume: 143 start-page: 110102 year: 2020 article-title: SARS‐CoV‐2 infection pathogenesis is related to oxidative stress as a response to aggression publication-title: Medical Hypotheses – volume: 202 start-page: 991 issue: 7 year: 2010 end-page: 1001 article-title: Influenza virus—cytokine‐protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza publication-title: The Journal of Infectious Diseases – ident: e_1_2_4_4_1 doi: 10.3390/molecules25092076 – ident: e_1_2_4_9_1 doi: 10.1016/j.fct.2020.111521 – ident: e_1_2_4_3_1 doi: 10.1016/j.mehy.2020.110102 – volume: 22 start-page: 334 issue: 4 year: 2019 ident: e_1_2_4_13_1 article-title: Immunoregulatory and anti‐inflammatory properties of Crocus sativus (Saffron) and its main active constituents: A review publication-title: Iranian Journal of Basic Medical Sciences contributor: fullname: Zeinali M. – ident: e_1_2_4_2_1 doi: 10.1155/2017/1702967 – ident: e_1_2_4_6_1 doi: 10.1186/s12931-018-0766-3 – ident: e_1_2_4_11_1 doi: 10.1086/656044 – ident: e_1_2_4_10_1 doi: 10.3390/antiox9060518 – ident: e_1_2_4_5_1 doi: 10.1016/j.arcmed.2020.04.019 – ident: e_1_2_4_12_1 doi: 10.1016/j.lfs.2019.116794 – ident: e_1_2_4_7_1 doi: 10.1002/jcb.26335 – ident: e_1_2_4_8_1 doi: 10.1111/bph.15157 |
SSID | ssj0002964 |
Score | 2.4008899 |
Snippet | The current COVID‐19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel... The current COVID-19 pandemic is one of the most devastating events in recent history. In the lack of a specific treatment and vaccine for this novel... Crocin can alleviate the uncontrolled cytokine production responsible for acute lung injury Crocin with immunomodulatory and anti‐inflammatory effects and... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e13718 |
SubjectTerms | COVID‐19 crocin NF‐κB Nrf2 PPARγ SARS‐CoV2 |
SummonAdditionalLinks | – databaseName: Wiley Online Library dbid: DR2 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LatwwFL0M2aSbtklfTtMgaOmi4GE8kmUZsklnMiSBTKHMlGyK0ct0aGKHjLNIVvmEfmO_JFfyI5kECg3Y2NiykHWvpHPtoyOATyIfMplgmKrQn0JmIxUqYfNQMBwvRC60zt185-MpP5izo5P4pAe77VyYWh-i--DmWobvr10Dl2p5v5HnSvcjin0rdsB4dHyu8fc77Sj3P7HmL8Yhhnms0Sb1NJ7u0dXR6BHEfMyUvI9g_RA0eQE_28LXzJPf_ctK9fX1A13Hp77dS3jeYFOyVzvTBvRssQnBeGEr8pk0AqKnZNrq92_CejutefkKZodupkl5Vhq3IFh5cUVkYXCvFn9v_qAbo-ed1dfPy8pRlDCrMidYL3pRENxG334cjjFtlJKO_f4a5pP92eggbJZsCDXGeSJkJrEqTQ01PGZWKqk1l5qLmElJUyHTRGKElvJhKk3MKcZDVA94nkhjB8JIRt_AWlEW9h2QAdWpEYM4VxZRpcG4MBoqHkcUAZiwVgXwsTVddl4rc2RdRIO1l_naC2C7tWrWtM5lhrBPJAKBMg_gbW3gLgvqJAsRNQWQrJi-S-D0uFfvFItfXpcbg22H-AL44i37j1JlR5OvI3-29T-J38OzoaPUeL7lNqxVF5f2A2KiSu14378FA7EKew priority: 102 providerName: Wiley-Blackwell |
Title | Immunomodulatory and anti‐inflammatory potential of crocin in COVID‐19 treatment |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjfbc.13718 https://www.ncbi.nlm.nih.gov/pubmed/33817822 https://www.proquest.com/docview/2508780206 https://pubmed.ncbi.nlm.nih.gov/PMC8250063 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEB50vYgHFV_VVQp6ErpumzZNT4KriwoqiK9byau46Lardg968if4G_0lTrLt-gIPQgulDWWSmWa-Sb_MAGyxLAh5jGGqQHvyQu0LTzCdeSxEf8EyJmVm9jufnNLDy_D4JrqpFtyeKlplPSfaiVoV0qyR76CrZjFDcEN3Bw-eqRpl_q5WJTQmYYqwKGANmOqcXR3tV3lILWUnE7Llk9hU9fjqeX7Byd-syK9o1bqb7iyktaAjlslda1iKlnz5kcPx_z2Zg5lrLdx67X4eJnS-ABdHZrNI0S-UqelVPD67PFd4lr331ze0RDSe_uj-oCgNy4jfu0XmYndlL3fxsKOCbf3EHRPYF-Gye3DROfSqqguexFCNeaGKtUgSRRSNQs0Fl5JySVkUck4SxpOYY5CV0CDhKqIEQxoi2zSLudJtpnhIlqCRF7leAbdNZKJYO8qERmCoMLTzA0EjnyCGYloLBzZrjaSDUXKNdByUoN5SqzcHmvU4ptUH9pR-DqIDyyO9jV9BTNZBBD4OxN80Om5gUmp_f5L3bm1qbYyXDWhzYNvq_g-p0uPuXsderf4t3xpMB4YHY0mSTWiUj0O9jkCmFBuVtW4glD8PPgBayft6 |
link.rule.ids | 230,315,783,787,888,1378,27936,27937,38528,43907,46306,46730 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LTtwwFL2isGjVRUGlJZRHpLJCyjSJE8dZIXVgNEN5bIaWXeRXxIhOMgxh0a74BL6RL-m18-AlsaiUSFFiRbav43uOc3wvwA7Lw4gnSFMFjicv0oHwBNO5xyL0FyxnUuZmv_PxCR2eRYfn8Xmz4HbdyCrbOdFO1KqUZo38G7pqljAEN3RvduWZrFHm72qTQuMNLKFj9ZF8LfVPf472mzikVrKTC9kLSGKyejz2PC_g5EtV5GO0at3N4ANkbUVrlcll76YSPfn3WQzH_2_JMrz_pYXbrt2vwIIuPsJ4ZDaLlNNSmZxe5fyPywuFZzW5v73DkYiDZ1rfn5WVURnx326Zu9hcOSlcPGyvYNkgdTsB-yqcDQ7G_aHXZF3wJFI15kUq0SJNFVE0jjQXXErKJWVxxDlJGU8TjiQrpWHKVUwJUhoifZonXGmfKR6RT7BYlIVeA9cnMlXMj3OhERgqpHZBKGgcEMRQTGvhwNfWItmsDq6RdaQE7ZZZuzmw0fZj1nxg19lDJzrwubZb9wpiog4i8HEgeWLRroAJqf30STG5sKG1kS8b0ObArrX9K7XKDgff-_Zq_fX6bcPb4fj4KDsanfz4Au9Co4mxgskNWKzmN3oTQU0ltpqR-w9Pd_14 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UCuqL1XqLrTqg-CBk2exMJhPoi-66dKuuIq30pYS54qJNljZ90Cd_Qn-jv8Qzk4tdC4JCAiGZDJM5czLfSb7zDcAz4UZMZhimKhxPMbOJipWwLhYM5wvhhNbO5zu_m_PdA7Z3mB6uwU6XC9PoQ_Qf3LxnhPe1d_ClcRed3Ck9SCi-W6_AVcYR-npI9PG3eJT_odgQGNMY4zzWipMGHk9_7-p0dAljXqZKXoSwYQ6absBR1_qGevJlcFargf7-h7Dj_z7eLbjZglPyshlNt2HNlpsQTRa2Js9JqyD6lcw7Af9NuN7lNZ_egf2ZTzWpjivjVwSrTr4RWRrc68XPH-c4jnHoHTfnl1XtOUpYVeUI9otelAS38ftPswmWTXLS09_vwsH09f54N27XbIg1BnoiZiazKs8NNTxlViqpNZeai5RJSXMh80xiiJbzUS5NyikGRFQPucuksUNhJKP3YL2sSvsAyJDq3Ihh6pRFWGkwMExGiqcJRQQmrFURPO1MVywbaY6iD2mw94rQexFsd1YtWvc8LRD3iUwgUuYR3G8M3FdBvWYhwqYIshXT9wW8IPfqlXLxOQhzY7TtIV8EL4Jl_9KqYm_6ahyOHv5L4Sdw7cNkWrydzd9swY2Rp9cE7uU2rNcnZ_YR4qNaPQ5u8Atd2w1C |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Immunomodulatory+and+anti%E2%80%90inflammatory+potential+of+crocin+in+COVID%E2%80%9019+treatment&rft.jtitle=Journal+of+food+biochemistry&rft.au=Ghasemnejad%E2%80%90Berenji%2C+Morteza&rft.date=2021-05-01&rft.pub=John+Wiley+and+Sons+Inc&rft.issn=0145-8884&rft.eissn=1745-4514&rft.volume=45&rft.issue=5&rft_id=info:doi/10.1111%2Fjfbc.13718&rft_id=info%3Apmid%2F33817822&rft.externalDBID=PMC8250063 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0145-8884&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0145-8884&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0145-8884&client=summon |